Nanomedicine Congress 2019

Nov 22-23, 2019

Sydney, Australia

Pharmaceutical Nanotechnology & Nanomedicine Congress 2019


Lexis consider it a privilege and a matter of great pride to host Conference on Pharmaceutical Nanotechnology & Nanomedicine Congress is to be held at Sydney, Australia for the duration of November 22 -23, 2019. On this auspicious occasion, Organizing Committee invites the participants from all over the world to take part in this annual flagship conference with the theme Exploring the Progress of Nanomedicine  with Trending Nanotechnologies.  The conference will provide a forum for interaction among attendees on Pharmaceutical Nanotechnology, Development of Nanotechnology-enabled Devices, Micro Fluidics platform for  Nano Particle Synthesis, Toxicology and Risk Assessment of Nanomedicine Systems, Medical  Nano Devices and Biosensors, Synthesis of Nanoparticles for Drug Delivery, Nanomedicine for Imunne System and Cancer Diagnosis & Theraphy.

This global meeting will assemble the world leaders in the expanding fields related to Pharmaceutical Nanotechnology & Nanomedicine. It will create an interface among professionals, academic faculty members, Researchers, Nanotech representatives and students, Nanotechnologists, Manufacturing Medical Device and experts in the fields of Nanotechnology., industry practitioners. The Conference will also have a room for companies and/or institutions to present their services, products, revolutions and research results.

Global Market for Nanotechnology products was priced $22.9 billion in 2013 and unanticipated increased to about $26 billion in 2014. This market is await  to reach about $64.2 billion by 2019; a compound annual growth rate (CAGR) is 19.8% from 2014 to 2019. The global market for nanotechnology-enabled printing technology was approximate to be at total $14 billion in 2013. The market is anticipate to grow at a compound annual growth rate (CAGR) of 17.7% over the next five years and to total $31.8 billion by 2018.

Masaki Otagiri
Pharmaceutical Sciences
Sojo University, Kumamoto, Japan.


Dr. Masaki Otagiri is currently a Professor Faculty of Pharmaceutical Sciences and DDS Research Institute , Sojo University. He graduated from Nagoya City University with a PhD degree in 1975. In 1980, he joined the Pharmaceutics Department of Faculty of

Program Overview

Our Collaborations, Sponsors, Media Partners